Cantrell Drug Co., In re--Cantrell Drug Co. v. United States

Ruling: 
Court concluded that an FDA action was excepted from automatic stay where the FDA was seeking primarily injunctive relief and would not have enjoyed an economic advantage over the debtor's creditors. (Bankr. E.D. Ark.)
Issue: 
Automatic Stay; Exceptions; Governmental Unit's Enforcement of Police or Regulatory Power.
ABI Membership is required to access the full summary of Cantrell Drug Co., In re--Cantrell Drug Co. v. United States. Please sign in if you are already an ABI member, or otherwise you may Become an ABI Member
Commercial case opionion summary, case decided on April 04,2018, LexisNexis #0518-033